what is a glp-1 injection pens Needles, and pressure: The challenge GLP-1 Weight Loss Results Explained:

Applying the causal roadmap to longitudinal national registry data: a case study of second-line diabetes medication and dementia

A sizable minority experience side effects like nausea

Combining tirzepatide with hormone therapy adds roughly 35% more weight loss per Mayo Clinic ENDO 2025, especially relevant for hormonal belly fat redistribution

Forest plot highlighting the risk of any cancer in the tirzepatide versus pooled control groups

If consistent access matters more than maximum potency, older medications with established manufacturing capacity deserve serious consideration

Because of these risks, doctors may choose to prescribe very small doses of GLP-1s to people with type 1 diabetes, especially if they do not have a lot of weight to lose